Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Completed
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
Sex: All
Age: 18 Years / N/A
No Study Documents
Sex: All
Age: 18 Years / N/A
No Study Documents